Growth hormone is one of 235 small molecule programs targeting Small for gestational age. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
190 competitors in Obesity
Synthroid
Vivia
Enavogliflozin
IBI362
Growth hormone
Mibavademab
Elecoglipron
PF-08653944
Survodutide
Aleniglipron
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources